The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america†
Open accessAbstract
In some, but not all countries, porphyria cutanea tarda (PCT) has been associated with chronic infection with the hepatitis C virus (HCV). Recently, PCT has also been associated with mutations in the HFE gene that are associated with HLA-linked hereditary hemochromatosis. Until now, few studies of these associations have been reported from North America. The aims of this study were: 1) to assess the prevalence of HCV infection and HFE mutations in North American patients with PCT; 2) to compare demographic and laboratory features between those who are HCV-positive and HCV-negative; and 3) to study urinary porphyrin excretions in American HCV-positive patients without clinically manifest PCT. Clinical and laboratory data, including tests for HCV and urinary porphyrins, were collected from 70 unselected patients with typical PCT. Urinary porphyrins were also measured in 110 non-PCT patients with chronic hepatitis C. Mutational analyses of the HFE gene were performed in 26 PCT patients. Thirty-nine of 70 (56%) of the PCT patients had evidence of HCV infection. Thirty-two of 39 PCT patients with HCV were men, all of whom used alcohol. In contrast, 22 of 31 PCT patients without HCV infection were women, 12 of whom had taken estrogens. The HCV-positive group was more likely to have used illicit intravenous drugs (45% vs. 0%; P = 0.01), to have had several (>4) sex partners (48% vs. 13%; P = 0.005), and less likely to have no known risk factors for HCV infection (33% vs. 78%; P = 0.004). Total urinary porphyrin excretion was the same in the two groups, but those with HCV infection had a significantly lower percentage of uroporphyrin and higher percentages of hepta-and hexa-carboxy porphyrins in urine. Sixteen of 110 (15%) HCV-positive subjects without PCT had increased urinary porphyrins, but, unlike PCT, these were mainly coproporphyrin. Forty-two percent of PCT patients carried the C282Y mutation of HFE (15% homozygous), and another 31% carried the H63D mutation (8% homozygous). Thus, 73% of PCT patients had one of these mutations. The prevalence of HCV infection (56%) and mutations in the HFE gene (73%) are high among North American patients with PCT. Alcohol and estrogen use are important additional risk factors. All PCT patients should be tested for HCV infection and for HFE gene mutations. Although HCV infection is a trigger for PCT, preclinical PCT is rare in chronic HCV hepatitis C in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., & Maertens, G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 685
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Self-citationExperimental liver cirrhosis induced by alcohol and iron.
Tsukamoto, H., Horne, W., Kamimura, S., Niemelä, O., Parkkila, S., Ylä-Herttuala, S., & Brittenham, G. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118077 · Cited by 513
Hepatic pathology in relatives of patients with hæmochromatosis
Scheuer, P. J., Williams, R., & Muir, A. R. (1962) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700840107 · Cited by 431
Iron and Chronic Viral Hepatitis
Bonkovsky, H. L., Banner, B. F., & Rothman, A. L. (1997) · Hepatology · doi:10.1002/hep.510250345 · Cited by 335
Self-citationIncreased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda
Roberts, A. G., Whatley, S. D., Morgan, R. R., Worwood, M., & Elder, G. H. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09436-6 · Cited by 316
Hepatitis C Virus and Porphyria Cutanea Tarda: Evidence of A Strong Association
Fargion, S., Piperno, A., Cappellini, M. D., Sampietro, M., Fracanzani, A. L., Romano, R., Caldarelli, R., Marcelli, R., Vecchi, L., & Fiorelli, G. (1992) · Hepatology · doi:10.1002/hep.1840160603 · Cited by 289
Elder, G. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007142 · Cited by 267
High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda
Sampietro, M., Piperno, A., Lupica, L., Arosio, C., Vergani, A., Corbetta, N., Malosio, I., Mattioli, M., Fracanzani, A. L., Cappellini, M. D., et al. (1998) · Hepatology · doi:10.1002/hep.510270128 · Cited by 198
The Significance of the 187G (H63D) Mutation in Hemochromatosis
BEUTLER, E., & AUGUST, A. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64339-0 · Cited by 181
Schiff, E. R. (1997) · Hepatology · doi:10.1002/hep.510260707 · Cited by 180
Tong, M. J., Reddy, K. R., Lee, W. M., Pockros, P. J., Hoefs, J. C., Keeffe, E. B., Hollinger, F. B., Hathcote, E. J., White, H., Foust, R. T., et al. (1997) · Hepatology · doi:10.1002/hep.510260330 · Cited by 179
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda
Decastro, M., Sánchez, J., Herrera, J. F., Cháves, A., Durán, R., Buey, L. G., García‐Monzón, C., Sequí, J., & Moreno‐Otero, R. (1993) · Hepatology · doi:10.1002/hep.1840170405 · Cited by 148
Bonkovsky, H. L., Healey, J. F., Lourie, A. N., & Gerron, G. G. (1991) · PubMed · Cited by 114
Self-citationHepatology: A Textbook of Liver Disease
Iber, F. L. (1990) · JAMA · doi:10.1001/jama.1990.03450130129042 · Cited by 100
Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany
Stölzel, U., Köstler, E., Koszka, C., Stöffler-Meilicke, M., Schuppan, D., Somasundaram, R., Manfred Otto, D. O. S. S., Habermehl, K. O., & Riecken, E. O. (1995) · Hepatology · doi:10.1002/hep.1840210604 · Cited by 97
Iron in Liver Diseases Other than Hemochromatosis
Bonkovsky, H. L., Banner, B. F., Lambrecht, R. W., & Rubin, R. L. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007220 · Cited by 92
Self-citationMukerji, S. K., Pimstone, N. R., & Burns, M. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90189-6 · Cited by 75
Self-citationTherapy of hepatitis C: Other options
Bonkovsky, H. L. (1997) · Hepatology · doi:10.1002/hep.510260725 · Cited by 71
Self-citationMutations of the Hereditary Hemochromatosis Candidate GeneHLA-Hin Porphyria Cutanea Tarda
Santos, M. M., Clevers, H. C., & Marx, J. J. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361817 · Cited by 71
Bonkovsky, H. L., Wood, S. G., Howell, S. K., Sinclair, P. R., Lincoln, B. C., Healey, J. F., & Sinclair, J. F. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90224-1 · Cited by 69
Self-citationMorán‐Jiménez, M., Fontanellas, A., Brudieux, E., Hombrados, I., de Lédinghen, V., Couzigou, P., de Verneuil, H., & de Salamanca, R. E. (1998) · Hepatology · doi:10.1002/hep.510270237 · Cited by 66
Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload
Elder, G. H., & Worwood, M. (1998) · Hepatology · doi:10.1002/hep.510270142 · Cited by 62
Siersema, P. D., Rademakers, L. H. P. M., Cleton, M. I., ten Kate, F. J. W., de Bruijn, W. C., Marx, J. J. M., & Wilson, J. H. P. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80004-2 · Cited by 51
Bonkovsky, H. L., Ponka, P., Bacon, B. R., Drysdale, J., Grace, N., & Tavill, A. S. (1996) · Hepatology · doi:10.1002/hep.510240341 · Cited by 47
Self-citationAscorbic acid deficiency in porphyria cutanea tarda
Sinclair, P. R., Gorman, N., Shedlofsky, S. I., Honsinger, C. P., Sinclair, J. F., Karagas, M. R., & Anderson, K. E. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90096-2 · Cited by 44
Banner, B. F., Barton, A. L., Cable, E. E., Smith, L., & Bonkovsky, H. L. (1995) · PubMed · Cited by 37
Self-citationIron and Chronic Viral Hepatitis: Emerging Evidence for an Important Interaction
Rubin, R. B., Barton, A. L., Banner, B. F., & Bonkovsky, H. L. (2008) · Digestive Diseases · doi:10.1159/000171504 · Cited by 34
Self-citationSimple and Rapid Detection of the Newly Described Mutations in the HLA-H Gene
Martínez, P., Jeanjean, P., Masmejean, C., Guillard, A., Biron‐Andréani, C., Rabesandratana, H., & Schved, J. (1997) · Blood · doi:10.1182/blood.v89.5.1835 · Cited by 34
Ascorbic Acid Inhibition of Cytochrome P450-Catalyzed Uroporphyrin Accumulation
Sinclair, P. R., Gorman, N., Walton, H. S., Bement, W. J., Jacobs, J. M., & Sinclair, J. F. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1376 · Cited by 28
Cited by
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
HFE Gene and Hereditary Hemochromatosis: A HuGE Review
Hanson, E. H. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.193 · Cited by 432
Metadata
- Authors
- Bonkovsky, H. L., Poh-Fitzpatrick, M., Pimstone, N., Obando, J., Di Bisceglie, A., Tattrie, C., Tortorelli, K., LeClair, P., Mercurio, M. G., & Lambrecht, R. W.
- Venue
- Hepatology
- Published
- 1998-06
- Volume
- 27
- Issue
- 6
- Pages
- 1661-1669
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2091464815
- Cited by
- 270
- References
- 32
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.